Tyrosinase Overexpression Promotes ATM-Dependent p53 Phosphorylation by Quercetin and Sensitizes Melanoma Cells to Dacarbazine
Dacarbazine (DTIC) has been used for the treatment of melanoma for decades. However, monotherapy with this chemotherapeutic agent results only in moderate response rates. To improve tumor response to DTIC current clinical trials in melanoma focus on combining a novel targeted agent with chemotherapy...
Main Authors: | Thilakavathy Thangasamy, Sivanandane Sittadjody, Kirsten H. Limesand, Randy Burd |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2008-01-01
|
Series: | Cellular Oncology |
Online Access: | http://dx.doi.org/10.3233/CLO-2008-0441 |
Similar Items
-
Quercetin abrogates chemoresistance in melanoma cells by modulating DeltaNp73
by: Thangasamy, Thilakavathy, et al.
Published: (2010) -
Quercetin abrogates chemoresistance in melanoma cells by modulating ΔNp73
by: Radhakrishnan Vijayababu M, et al.
Published: (2010-06-01) -
Quercetin as an Emerging Anti-Melanoma Agent: A four-focus area therapeutic development strategy
by: Zoey Harris, et al.
Published: (2016-10-01) -
Dacarbazine combined targeted therapy versus dacarbazine alone in patients with malignant melanoma: a meta-analysis.
by: Guan Jiang, et al.
Published: (2014-01-01) -
Effects of Quercetin on Mushroom Tyrosinase and B16-F10 Melanoma Cells
by: Ken-ichi Nihei, et al.
Published: (2007-05-01)